GlassScriptPhysician profile
Farrukh Ansari
NPI 1174814933
$5,699.44
in general payments reported to CMS, 2019-2025
21 companies · $505 in 2025
The $505 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $414 · 2021: $468 · 2022: $518 · 2023: $2,292 · 2024: $606 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Travel and Lodging: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.92 |
| Travel and Lodging | $1,341.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,472.40 | 2023 | |
| Boston Scientific Corporation | $1,114.91 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,093.97 | 2019-2024 | Senza |
| Abbott Laboratories | $676.42 | 2019-2023 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $287.46 | 2023-2025 | Evoke, Evoke Scs |
| Arthrex, INC. | $270.08 | 2023 | |
| Allergan, INC. | $175.66 | 2019-2021 | |
| Globus Medical, INC. | $110.84 | 2025 | Senza |
| International Rehabilitative Sciences, INC | $99.93 | 2023-2025 | Rs 4i Plus Sequential Stimulator |
| Vertex Pharmaceuticals Incorporated | $75.66 | 2024-2025 | |
| Axonics, INC. | $55.90 | 2024 | Axonics |
| Medtronic, INC. | $46.24 | 2024 | Intellis Adaptivestim |
| Foundation Fusion Solutions, LLC | $42.48 | 2020-2024 | |
| Vertos Medical, INC. | $41.88 | 2022 | |
| Scilex Pharmaceuticals INC. | $40.13 | 2019-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $22.48 | 2020 | |
| Relievant Medsystems, INC. | $21.27 | 2021 | |
| Abbvie INC. | $20.98 | 2024 | |
| Depuy Synthes Sales INC. | $18.49 | 2022 | |
| Pfizer INC. | $10.82 | 2019 | |
| Spr Therapeutics, INC | $1.44 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farrukh Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.